BIIB vs ROOT · P/E 21, rev $9.89B vs P/E 14, rev $1.18B
Biogen Inc (BIIB) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the BIIB and ROOT stock pages for the full models.
Not investment advice.